Clinical and Practical Psychopharmacology
Clinical and Practical Psychopharmacology
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, Part 3
September 28, 2016
Patients with schizophrenia have increased rates of many cardiometabolic risk factors. Chittaranjan Andrade, MD, takes a look at the impact of pharmacological interventions, such as metformin, topiramate, and aripiprazole,…
Clinical and Practical Psychopharmacology
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, Part 2
August 24, 2016
Patients with schizophrenia have increased rates of many cardiometabolic risk factors. In the second in a 2-part series, Chittaranjan Andrade, MD, looks at the impact of nonpharmacological interventions, such…
Clinical and Practical Psychopharmacology
Clinical and Practical Psychopharmacology: Cardiometabolic Risks in Schizophrenia and Directions for Intervention, Part 1
July 27, 2016
It’s well known that patients with schizophrenia have increased cardiometabolic risk factors. In the first of a 2-part series, Chittaranjan Andrade, MD, looks at the magnitude and the moderators…
